Syneron Medical

Closed portfolio snapshot

According to ClinicalTrials.gov-derived indexes, Syneron Medical sits in the top decile of US sponsors by registered trial count (#801 of 15,742 sponsors by registered trial count).

18 total trials none currently recruiting 17 completed top decile by trial count

Syneron Medical: 18 sponsored US clinical trials, none currently recruiting.

Syneron Medical sponsors 18 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 17 completed. 1 of these trials are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Abdominal Fat, with 1 trials.

Top-decile sponsor footprint

Syneron Medical ranks in the top decile of sponsors by registered trial count (#801 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

C 76/100

17 of 18 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (94.4%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Indexed trials (enrollment closed)

18 total, page 1 of 1

COMPLETED NA

VelaShape III & UltraShape Power for Thigh Circumference Reduction

NCT03430245

COMPLETED NA

Profound Dermal and SubQ Cartridges for the Treatment of Cellulite

NCT03078647

COMPLETED NA

SlimShape Device for Abdominal Fat and Circumference Reduction

NCT02999763

COMPLETED NA

UltraShape Power for Abdominal Fat and Circumference Reduction

NCT02748928

COMPLETED NA

Histological Study to Evaluate Skin Changes After PicoWay® 1064 nm and 532nm Picosecond Fractional Laser Treatment

NCT02700204

COMPLETED NA

Picosecond Laser for Ttreatment of Benign Pigmented Lesions

NCT02146820

COMPLETED NA

Laser Treatment of Tattoos With Pico Laser

NCT02146807

COMPLETED NA

VelaShape III Device in Comparison to Cryolipolysis for Circumferential Reduction

NCT02143960

COMPLETED NA

Surgical Scar Treatment With the Pulsed Dye Laser in Combination With a CO2 Laser

NCT02898350

COMPLETED NA

Safety and Efficacy of the Luxe Device to Treat Facial Wrinkles and Rosacea

NCT01618864

COMPLETED NA

Hair2Go Label Comprehension and Usability Study

NCT01578187

COMPLETED NA

Long Term Efficiency of the Hair2Go Device

NCT01529931

COMPLETED NA

Safety for Frequent Use Conditions of Hair Removal Device

NCT01348789

COMPLETED NA

The Efficiency of the Hair2Go Device: A Prospective, Open, Label Study With Before-After Design

NCT01348776

COMPLETED NA

Port Wine Stains Treatment Matrix RF Study

NCT01101360

COMPLETED Phase 2

In-vivo Analysis and Clinical Evaluation of the Performance of a Fractional CO2 Laser System (eMatrixCO2)

NCT00992277

TERMINATED Phase 4

Clinical Study to Evaluate the Safety and Efficacy of the Vela100

NCT01026441

COMPLETED NA

Clinical Study to Evaluate the Performance of Fractional Radiofrequency for Improvement of Skin Texture Via Skin Resurfacing and Wrinkles Reduction

NCT00887913

Phase Distribution

PhaseTrial count
Phase 2 1
Phase 4 1

Therapeutic Areas

How the Syneron Medical archive is shaped

18 indexed studies, none listed as recruiting (0% open); 17 completed (94%).

Phase mix: 1 late (III/IV) vs 1 early (I/II) (balanced across stages).

Top condition: Abdominal Fat (1 trial), 1 other listed.

How to read a closed sponsor archive

When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.

Syneron Medical: archived-pipeline peers nationwide

Peers matched on 18 indexed studies with no current recruiting: volume and archive shape, not condition overlap.

Syneron Medical sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 05101520 0%10%20%30%40% Total trials Recruiting share Syneron MedicalADC Therapeutics S.A.Akros PharmaAO Clinical Investigation and Publishing DocumentationAO Innovation Translation Center10xBio22nd Century Group23andMe3-C Institute for Social Development
Syneron Medical sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Syneron Medical sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 18 archived trials

Sponsors with similar archive density (± trial count)

What to do with this Syneron Medical page

18 registered trials is a research-attention snapshot, not an endorsement of Syneron Medical or any single study.

  • None of Syneron Medical's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
  • Abdominal Fat is the condition Syneron Medical studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Abdominal Fat trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Syneron Medical pipeline card: 18 registered trials from official public datasets.Report a data error.